DUSP1 and neoplasm: In NSCLC cancer cell lines where DUSP1/MKP-1 was constitutively expressed, siRNA knockdown increased cisplatin sensitivity some 10 fold, reduced the growth of these cell lines in nude mice and rendered the resulting tumours cisplatin sensitive [63].